NEOPRANE, created in 2003 (Switzerland), from 126 sister brands and 279 competing brands. NEOPRANE is owned by GALENICA AG, listed on the stock exchange of Zurich The International Securities Identification Number (ISIN) of GALENICA AG is CH0360674466. NEOPRANE is part of the Medical Distribution activity sector.
Investment simulator :
Portfolio valuation
GALENICA AG
(NEOPRANE)
over 5 years*
CHF 97.33